87061 – cANCA IFA plus
The cANCA IFA plus is an immunofluorescence assay (IFA) for the qualitative and semi-quantitative determination of IgG antibodies in human serum against neutrophil cytoplasmatic antigens (ANCA) on ethanol fixed human granulocytes. The cANCA IFA plus is intended as an aid in the diagnosis of systemic vasculitis (SV) in conjunction with other clinical and laboratory findings.
The appearance of autoantibodies directed against components of the cell nucleus are characteristic features of systemic autoimmune diseases, especially; systemic lupus erythematosus (SLE), Sjögren’s syndrome, progressive systemic sclerosis (PSS), mixed connective tissue disease (MCTD), rheumatoid arthritis (RA) and dermatomyositis.
The detection of autoantibodies in patient sample, e.g. plasma and serum, is well established and plays an essential role in the diagnosis of systemic autoimmune diseases. Systemic vasculitis (SV) pathogenesis is majorly identified by the inflammation of different blood vessel walls, and the resulting morphological changes. Arteries and veins can both be affected simultaneously. The clinical manifestation is mainly indicated by general symptoms like exhaustion, fever and weight loss. Depending on which kind of vessels are affected, future disease course varies.
Anti-neutrophil cytoplasmic antibodies (ANCA) play an essential role in the serological diagnosis of SV. These antibodies are usually determined by indirect immunofluorescence using ethanol fixed human neutrophils. Cytoplasmic ANCA (cANCA) and perinuclear ANCA (pANCA) are distinguished based on the immunofluorescence pattern.
Cell fixation using ethanol destroys granular membranes in neutrophil cytoplasm, thus allowing positively charged proteins move to the negatively charged nucleus – the basis for ANCA screening substrate. cANCA antibodies are identified by a cytoplasmic fluorescence pattern, whereas pANCA antibodies must be differentiated from antibodies to nuclear antigens (ANA) which also show a (peri) nuclear pattern.
The IFA (indirect immunofluorescence assay) is an immunoassay for the determination of specific antibodies. Tissue sections or cells containing the antigen of interest are immobilized on slides. If specific antibodies are present in the patient´s sample, they bind to the antigen in the tissue. A secondary antibody conjugated with fluorescein-isothiocyanat (FITC) detects the generated immune complex. The slides are examined using a fluorescence microscope. A specific fluorescent staining pattern demonstrates the presence of specific antibodies in the patient´s sample.
The immunoassay is designed for manual professional in vitro diagnostic use.
|Title||cANCA IFA plus|
|Description||Indirect immunofluorescence assay .for the determination of IgG antibodies in human serum against neutrophil cytoplasmic antigens (ANCA)|
|Format||Slides coated with ethanol fixed human granulocytes|
|Total incubation time||60 min.|
|Sample volume||10 µL serum|
|No. of determinations||60 (10 x 6)|